BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT03193398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy And Safety Study Of BTRX-246040 Administered Once Daily In Patients With Major Depressive Disorder With Or Without Anhedonia
Study identification
- NCT ID
- NCT03193398
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- BlackThorn Therapeutics, Inc.
- Industry
- Enrollment
- 104 participants
Conditions and interventions
Conditions
Interventions
- BTRX-246040 oral capsule(s) Drug
- Placebo oral capsule(s) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2017
- Primary completion
- Nov 11, 2018
- Completion
- Dec 11, 2018
- Last update posted
- May 10, 2021
2017 – 2018
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United States | Cerritos | California | 90703 | — |
| United States | Garden Grove | California | 92845 | — |
| United States, Florida | Jacksonville | Florida | 32256 | — |
| United States | Lauderhill | Florida | 33319 | — |
| United States, Florida | Orlando | Florida | 32801 | — |
| United States | Libertyville | Illinois | 60048 | — |
| United States | Rochester | New York | 14618 | — |
| United States | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03193398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03193398 live on ClinicalTrials.gov.